Recovery heart rate after sub-maximal work.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 1263476)

Published in J Sports Med Phys Fitness on March 01, 1976

Authors

A Shapiro, Y Shoenfeld, Y Shapiro

Articles by these authors

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61

Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96

Rheumatology in Israel. Br J Rheumatol (1996) 2.66

Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus (2000) 2.40

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31

Hereditary haemorrhagic telangiectasia. Haemophilia (2008) 2.22

Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22

Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09

Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09

Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02

Bupivacaine wound instillation via an electronic patient-controlled analgesia device and a double-catheter system does not decrease postoperative pain or opioid requirements after major abdominal surgery. Anesth Analg (2001) 1.96

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91

Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87

Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope (1991) 1.85

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77

Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76

Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective? Clin Infect Dis (1998) 1.74

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69

No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58

Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group. Blood (1994) 1.54

Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52

Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50

Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49

The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48

Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48

Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48

Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases. Urology (1981) 1.47

Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant (1998) 1.47

Autoantibodies in neoplasia. An unresolved enigma. Cancer (1990) 1.45

Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44

Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44

The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44

Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum (1995) 1.44

The good, the bad and the ugly of vaccination. Isr Med Assoc J (2000) 1.43

Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol (1998) 1.42

Intravesical lidocaine: topical anesthesia for bladder mucosal biopsies. J Urol (1992) 1.41

A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology. Isr J Med Sci (1992) 1.41

Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol (1991) 1.40

Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci (1996) 1.40

Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol (1991) 1.40

Modulation of outflow resistance by the pores of the inner wall endothelium. Invest Ophthalmol Vis Sci (1992) 1.40

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39

Antiphospholipid antibody testing - slow progress? Int J Clin Pract (2012) 1.39

Isolated pulmonary blast injury in rats--a new model using the extracorporeal shock-wave lithotriptor. Mil Med (1989) 1.39

Screening for prostate cancer. Isr J Med Sci (1995) 1.38

[Viagra--the first oral treatment for impotence that is not lacking in fatal effects]. Harefuah (1998) 1.38

Effects of exposure to Finnish sauna. Isr J Med Sci (1976) 1.37

Extradural bupivacaine and methadone for extracorporeal shock-wave lithotripsy. Br J Anaesth (1989) 1.37

Refractive power of premature children at infancy and early childhood. Am J Ophthalmol (1980) 1.37

Mycobacteria and autoimmunity. Immunol Today (1988) 1.36

Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) (2006) 1.35

Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol (1997) 1.34

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31

A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B. Br J Haematol (1990) 1.29

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28

Noninvasive detection of bladder cancer with the BTA stat test. J Urol (1999) 1.26

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis (1998) 1.26

A homozygous chromosomal variant. Lancet (1969) 1.26

The mosaic of autoimmunity. Immunol Today (1989) 1.23

Exertional heat stroke: a case series. Med Sci Sports Exerc (1999) 1.22

Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology (2004) 1.22

Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol (1999) 1.21

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus (1999) 1.21

Thermoregulatory responses of patients with extensive healed burns. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.20

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19

Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol (2008) 1.18

Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18

Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med (1982) 1.17

Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum (1996) 1.17

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev (2010) 1.16

Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum (1987) 1.16

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15

Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med (1998) 1.14

The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis (2002) 1.14

Genetic analysis of Tourette syndrome suggesting major gene effect. Am J Hum Genet (1981) 1.14

What causes alopecia areata? Exp Dermatol (2013) 1.14

Cold-induced profuse sweating on back and chest. A new genetic entity? Lancet (1978) 1.14

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci (2007) 1.14

Diagnosis and management of renal angiomyolipoma. Urology (1985) 1.14

Treatment of pregnant patients with antiphospholipid syndrome. Lupus (2003) 1.13

Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol (1999) 1.13

Antiphospholipid syndrome induced by HIV. Lupus (2001) 1.13

Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus (2003) 1.13

Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg (1988) 1.12

The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12

Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia (2003) 1.10